Rongguo Qiu

3.0k total citations · 1 hit paper
24 papers, 2.5k citations indexed

About

Rongguo Qiu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Rongguo Qiu has authored 24 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Rongguo Qiu's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Microbial Natural Products and Biosynthesis (7 papers) and Cancer Treatment and Pharmacology (6 papers). Rongguo Qiu is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Microbial Natural Products and Biosynthesis (7 papers) and Cancer Treatment and Pharmacology (6 papers). Rongguo Qiu collaborates with scholars based in China, United States and Netherlands. Rongguo Qiu's co-authors include Marc Symons, Frank McCormick, David H. Kirn, Jing Chen, Arie Abo, Greg S. Martin, David Stokoe, Tony Evans, Rhodri Walters and A. Eguinoa and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Rongguo Qiu

24 papers receiving 2.5k citations

Hit Papers

An essential role for Rac in Ras transformation 1995 2026 2005 2015 1995 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongguo Qiu China 15 2.0k 973 498 267 212 24 2.5k
Konstantin Stoletov United States 22 1.3k 0.7× 836 0.9× 578 1.2× 217 0.8× 226 1.1× 37 2.3k
Wannian Yang United States 28 1.6k 0.8× 730 0.8× 346 0.7× 150 0.6× 170 0.8× 54 2.1k
Julie L. Wilsbacher United States 21 2.2k 1.1× 470 0.5× 700 1.4× 298 1.1× 405 1.9× 31 3.1k
Michael D. Waterfield United Kingdom 8 2.6k 1.3× 765 0.8× 630 1.3× 160 0.6× 402 1.9× 8 3.3k
Clark D. Wells United States 25 1.7k 0.8× 910 0.9× 244 0.5× 107 0.4× 222 1.0× 33 2.4k
Scott T. Eblen United States 24 1.8k 0.9× 552 0.6× 445 0.9× 172 0.6× 148 0.7× 41 2.3k
Roy Katso United Kingdom 13 1.9k 0.9× 466 0.5× 409 0.8× 125 0.5× 375 1.8× 15 2.6k
Stéphane Ory France 20 1.2k 0.6× 641 0.7× 291 0.6× 158 0.6× 187 0.9× 45 1.8k
Barbara Marte United States 19 2.3k 1.1× 484 0.5× 767 1.5× 208 0.8× 361 1.7× 36 3.0k
Jiing‐Dwan Lee United States 21 2.1k 1.1× 450 0.5× 472 0.9× 88 0.3× 230 1.1× 26 2.7k

Countries citing papers authored by Rongguo Qiu

Since Specialization
Citations

This map shows the geographic impact of Rongguo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongguo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongguo Qiu more than expected).

Fields of papers citing papers by Rongguo Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongguo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongguo Qiu. The network helps show where Rongguo Qiu may publish in the future.

Co-authorship network of co-authors of Rongguo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Rongguo Qiu. A scholar is included among the top collaborators of Rongguo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongguo Qiu. Rongguo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Min, Xinlan Liu, Shusen Wang, et al.. (2025). Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases. JAMA Oncology. 11(8). 883–883. 1 indexed citations
2.
Zhang, Pin, Zhongsheng Tong, Fuguo Tian, et al.. (2016). Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients. Journal of Hematology & Oncology. 9(1). 68–68. 19 indexed citations
3.
An, Fan, Weijie Zhao, Li Tang, & Rongguo Qiu. (2015). Concentration-dependent differential effects of an epothilone analog on cell cycle and p53 signaling. Oncology Reports. 34(3). 1361–1368. 3 indexed citations
4.
Su, Chun, Xin‐Qing Zhao, Rongguo Qiu, & Li Tang. (2014). Construction of the co-expression plasmids of fostriecin polyketide synthases and heterologous expression inStreptomyces. Pharmaceutical Biology. 53(2). 269–274. 8 indexed citations
6.
Liu, Xuejiao, et al.. (2013). Elucidation of the Biosynthetic Gene Cluster and the Post-PKS Modification Mechanism for Fostriecin in Streptomyces pulveraceus. Chemistry & Biology. 20(1). 45–54. 25 indexed citations
7.
Liu, Xuejiao, et al.. (2013). Identification of the Post-Polyketide Synthase Modification Enzymes for Fostriecin Biosynthesis in Streptomyces pulveraceus. Journal of Natural Products. 76(4). 524–529. 10 indexed citations
8.
Niu, Mingshan, Yan Sun, Bo Liu, Li Tang, & Rongguo Qiu. (2012). Differential Effects of Tautomycetin and Its Derivatives on Protein Phosphatase Inhibition, Immunosuppressive Function and Antitumor Activity. Korean Journal of Physiology and Pharmacology. 16(2). 145–145. 7 indexed citations
9.
Niu, Mingshan, Yan Sun, Xuejiao Liu, Li Tang, & Rongguo Qiu. (2012). Tautomycetin Induces Apoptosis by Inactivating Akt Through a PP1-Independent Signaling Pathway in Human Breast Cancer Cells. Journal of Pharmacological Sciences. 121(1). 17–24. 14 indexed citations
10.
Wang, Fen, et al.. (2012). Functional characterization of the genes tauO, tauK, and tauI in the biosynthesis of tautomycetin. The Journal of Microbiology. 50(5). 770–776. 4 indexed citations
11.
Zhang, Pin, Mingyuan Sun, Rongguo Qiu, et al.. (2011). Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 68(4). 971–978. 15 indexed citations
12.
Tang, Li, Rongguo Qiu, Yong Li, & Leonard Katz. (2003). Generation of Novel Epothilone Analogs with Cytotoxic Activity by Biotransformation.. The Journal of Antibiotics. 56(1). 16–23. 17 indexed citations
13.
McCabe, Peter C., et al.. (2000). Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis. Current Biology. 10(21). 1383–1386. 112 indexed citations
14.
Ahram, Mamoun, Mansoureh Sameni, Rongguo Qiu, et al.. (2000). Rac1-Induced Endocytosis Is Associated with Intracellular Proteolysis during Migration through a Three-Dimensional Matrix. Experimental Cell Research. 260(2). 292–303. 37 indexed citations
15.
Qiu, Rongguo, Arie Abo, & Greg S. Martin. (2000). A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCζ signaling and cell transformation. Current Biology. 10(12). 697–707. 238 indexed citations
16.
Ross, Annette H., et al.. (1997). Role of Rho Family Proteins in Phospholipase D Activation by Growth Factors. Journal of Biological Chemistry. 272(3). 1615–1620. 73 indexed citations
17.
Peppelenbosch, Maikel P., Leon G.J. Tertoolen, Alida M.M. de Vries-Smits, et al.. (1996). Rac-dependent and -independent Pathways Mediate Growth Factor-induced Ca2+ Influx. Journal of Biological Chemistry. 271(14). 7883–7886. 41 indexed citations
18.
Siddiqi, Abdur Rehman, et al.. (1995). Regulation of Phospholipase D in HL60 Cells. Journal of Biological Chemistry. 270(15). 8466–8473. 124 indexed citations
19.
Hawkins, Phillip T., A. Eguinoa, Rongguo Qiu, et al.. (1995). PDGF stimulates an increase in GTP–Rac via activation of phosphoinositide 3-kinase. Current Biology. 5(4). 393–403. 481 indexed citations
20.
Peppelenbosch, Maikel P., Rongguo Qiu, Leon G.J. Tertoolen, et al.. (1995). Rac mediates growth factor-induced arachidonic acid release. Cell. 81(6). 849–856. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026